What is the role of virus vaccination in patients with asthma?

Current Allergy and Asthma Reports

Volumn 7, Issue 1, 2007, Pages 72-76

  Bueving, Herman J ^a,b   van der Wouden, Johannes C ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORONA VIRUS VACCINE; CORTICOSTEROID; INACTIVATED VACCINE; INFLUENZA VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RHINOVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ASTHMA; CORONAVIRUS; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SCREENING; FLU LIKE SYNDROME; HUMAN; HUMAN RHINOVIRUS; INCIDENCE; INFECTION COMPLICATION; INFLUENZA; INFLUENZA VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

ASTHMA; COST-BENEFIT ANALYSIS; HUMANS; INFLUENZA VACCINES; VACCINATION; VIRAL VACCINES;

EID: 34247548724     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-007-0033-z     Document Type: Review

References (50)

1. Huurre TM, Aro HM, Jaakkola JJ: Incidence and prevalence of asthma and allergic rhinitis: a cohort study of Finnish adolescents. J Asthma 2004, 41:311-317.
2. Johnston NW, Sears MR: Asthma exacerbations. 1: epidemiology. Thorax 2006, 61:722-728.
3. Minor TE, Dick EC, DeMeo AN, et al.: Viruses as precipitants of asthmatic attacks in children. JAMA 1974, 227:292-298.
4. Johnston SL, Pattemore PK, Sanderson G, et al.: Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229.
5. Rawlinson WD, Waliuzzaman Z, Carter IW, et al.: Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J Infect Dis 2003, 187:1314-1318.
6. Bueving HJ, van der Wooden JC, Raat H, et al.: Influenza vaccination in asthmatic children: effects on quality of life and symptoms. Eur Respir J 2004, 24:925-931.
7. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982-986.
8. Atmar RL, Guy E, Guntupalli KK, et al.: Respiratory tract viral infections in inner-city asthmatic adults. Arcb Intern Med 1998, 158:2453-2459.
9. Tan WC: Viruses in asthma exacerbations. Curr Opin Pulm Med 2005, 11:21-26.
10. Johnston SL, Pattemore PK, Sanderson G, et al.: The relationship between upper respiratory infections and hospital admissions for asthma a time-trend analysis. Am J Respir Crit Care Med 1996, 154(3 Pt 1):654-660.
11. Izurieta HS, Thompson WW, Kramarz P, et al.: Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000, 342:232-239.
12. Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR: The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000, 137:856-864.
13. Dales RE, Schweitzer I, Toogood JH, et al.: Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J 1996, 9:72-77.
14. Teichtahl H, Buckmaster N, Pertnikovs E: The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997, 112:591-596.
15. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB: Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Disi 2000, 31:96-100.
16. Tan WC, Xiang X, Qiu D, et al.: Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003, 115:272-277.
17. Iwane MK, Edwards KM, Szilagyi PG, et al.: Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004, 113:1758-1764.
18. McKean M, Ducharme F: Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev 2000: CD001107.
19. Edmonds ML, Camargo CA jr, Pollack CV Jr, Rowe BH: Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003:CDO02308.
20. Rowe BH, Spooner C, Ducharme FM, et al.: Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001: CD002178.
21. Weinberger M: Treatment strategies for viral respiratory infection-induced asthma. J Pediatr 2003, 142(suppl. 2): S34-S38.
22. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases: The Jordan Report 20th Anniversary: Accelerated Development of Vaccines 2002. http://www.niaid.nih.gov/dmid/vaccines/jordan20/
23. Hayden FG: Rhinovirus and the lower respiratory tract. Rev Med Virol 2004, 14:17-31.
24. Blomqvist S: Epidemiology of human rhinoviruses [PhD thesis]. Helsinki, Finland: University of Helsinki; 2004.
25. Falsey AR, Hennessey PA, Formica MA, et al.: Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005, 352:1749-1759.
26. Weinberger M: Clinical patterns and natural history of asthma. J Pediatr 2003, 142(suppl 2):S15-Sl9.
27. Durbin AP, Karron RA: Progress in te development of respiratory syncytial virus and parainfluenza virus vaccines. Clin Infect Dis 2003, 37:1668-1677.
28. van Essen GA, Palache AM, Forleo E, Fedson DS: Influenza accination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003, 21:1780-1785.
29. Greenberg SB: Respiratory viral infections in adults. Curr Opin Pulm Med 2002, 8:201-208.
30. World Health Organization: WHO 2003: Influenza Factsheet. http://www.who.int/mediacentre/factsheets/2003/fs2ll/en/ Accessed July 2006.
31. Meier CR, Napalkov PN, Wegmuller Y, et al.: Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000, 19:834-842.
32. Poehling KA, Edwards KM, Weinberg GA, et al.: The underrecognized burden of influenza in young children. N Engl J Med 2006, 355:31-40.
33. Govaert TM, Thijs CT, Masurel N, et al.: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994, 272:1661-166S.
34. Bueving HJ, Bernsen RM, de Jongste JC, et al.: Influenza vaccination in children with asthma- randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004, 169:488-493.
35. Heikkinen T, Silvennoinen H, Peltola V, et al.: Burden of influenza in children in the community. J Infect Dis 2004, 190:1369-1373.
36. Monto AS: Invited Commentary. Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. Am J Epidemiol 2003, 158:312-315.
37. Bueving HJ, van der Wouden JC, Berger MY, Thomas S: Incidence of influenza and associated illness in children aged 0-19 years: a systematic review. Rev Med Virol 2005, 15:383-391.
38. Demicheli V, Rivetti D, Deeks J, Jefferson T. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2004, 3:CDO01269.
39. Jefferson T, Smith S, Demicheli V, et al.: Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005, 365:773-780.
40. Villari P, Manzoli L, Boccia A: Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 2004, 22:3475-3486.
41. Smits AJ, Hak E, Stalman WA, et al.: Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 2002, 128:205-211.
42. Christy C, Aligne CA, Auinger P, et al.: Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004, 89:734-735.
43. Abadoglu O, Mungan D, Pasaoglu G, et al.: Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. J Asthma 2004, 41:279-283.
44. Cates CJ, Jefferson TO, Bara Al, Rowe BH: Vaccines for preventing influenza in people with asthma. Cochrane Database Syst Rev 2004:CD000364.
45. Gessner BD: The cost-effectiveness of a hypothetical respiratory syncytial virus vaccine in the elderly. Vaccine 2000, 18:1485-1494.
46. Turner D, Wailoo A, Nicholson K, et al.: Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003, 7:iii-iv, xi-xiii, 1-170.
47. Nichol KL, Nordin J, Mullooly J: Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. Vaccine 2006, 24:1562-1568.
48. Demicheli V, Jefferson T, Rivetti D, Deeks J: Prevention and early treatment of influenza in healthy adults. Vaccine 2000, 18:957-1030.
49. Hak E, van Essen GA, Buskens E, et al.: Is immunizing all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. J Epidemiol Community Health 1998, 52:120-125.
50. Dayan GH, Nguyen VH, Debbag R, et al.: Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001, 19:4204-4213.